en
Scientific article
English

Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis

Published inCirculation. Heart failure, vol. 7, no. 3, p. 409-417
Publication date2014
Abstract

Fibroblast growth factor-23 (FGF-23) is a phosphate regulatory hormone that directly stimulates left ventricular hypertrophy in experimental models. The role of FGF-23 in cardiovascular disease development in the general population is unclear. We tested associations of FGF-23 with major subclinical and clinical cardiovascular disease outcomes in a large prospective cohort.

Keywords
  • Aged
  • Aged, 80 and over
  • Atherosclerosis/blood/epidemiology/ethnology
  • Biomarkers/blood
  • Calcium/metabolism
  • Cardiovascular Diseases/blood/epidemiology/ethnology
  • Carotid Intima-Media Thickness
  • Cohort Studies
  • Coronary Vessels/metabolism
  • Female
  • Fibroblast Growth Factors/blood
  • Heart Ventricles/pathology
  • Humans
  • Incidence
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • United States
Citation (ISO format)
KESTENBAUM, Bryan et al. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis. In: Circulation. Heart failure, 2014, vol. 7, n° 3, p. 409–417. doi: 10.1161/CIRCHEARTFAILURE.113.000952
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1941-3289
364views
0downloads

Technical informations

Creation10/30/2016 1:28:00 PM
First validation10/30/2016 1:28:00 PM
Update time03/15/2023 12:57:02 AM
Status update03/15/2023 12:57:02 AM
Last indexation10/19/2023 2:26:36 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack